Your absence policy isn’t enough: Why cancer needs its own framework

Summary

Research cited in the article shows 96% of UK organisations do not have a dedicated cancer policy, leaving over a million working-age people to navigate cancer through generic absence frameworks. The piece argues cancer is a long-term, often unpredictable condition that commonly requires ongoing management rather than a single episode of absence.

The author explains why returning to work matters beyond income (identity, routine, social connection) and outlines how current inconsistent support creates a lottery: some employees get helpful adjustments, others face rigid rules or feel forced into leaving. The article recommends cancer-specific policies that specify sick pay from diagnosis, flexible working, phased returns and carer support, and stresses collaborative policy design and manager training.

It finishes with practical next steps: audit existing provision, consult people with lived experience, form a working group, pilot a policy and use specialist guidance from organisations such as Working With Cancer. The approach also scales to other long-term conditions, strengthening culture and retention.

Key Points

96% of UK organisations lack dedicated cancer policies, creating inconsistent support for more than one million working-age people with cancer.
Cancer is often a chronic, long-term condition (e.g. endocrine therapy for breast cancer can last 5–10 years), not a one-off absence.
Returning to work matters for identity, routine and social connection, not just income.
Work-related stress, fear of recurrence and treatment side effects make standard absence frameworks inadequate and can drive burnout or exit.
Effective cancer-specific policies should include clear sick pay rules from diagnosis, flexible working, phased returns and carer support.
Policies must be co-produced with HR, occupational health, unions and employees with lived experience and backed by manager training and real-world case workshops.
Starting steps: audit current provision, gather workforce data, form a working group, pilot a policy and seek specialist guidance.

Why should I read this?

Short and sharp: if you think your absence policy covers everything, you’re probably wrong. This article shows why cancer needs its own playbook — for fairness, legal protection and keeping talented people at work. Read it if you want practical reasons and first steps to stop support being a postcode lottery.

Author style

Punchy and direct — the piece makes a clear case that this isn’t a niche HR tweak but a material people and legal risk. If you care about retention, values-led recruitment or simply doing the decent thing, the article amplifies why detail matters and why you should act.

Context and relevance

The article sits at the intersection of wellbeing, inclusion and employment law (Equality Act 2010). With ageing workforces and longer survivorship, employers face growing numbers of people managing long-term treatments while working. A cancer-specific framework reduces legal risk, supports retention and can be adapted to other chronic conditions (diabetes, chronic pain, neurological conditions), improving organisational culture and competitiveness in the labour market.